Abatacept for Treatment of Recurrent or de Novo Autoimmune Hepatitis

NCT04203875 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Lack of eligible study participants.

Conditions

Autoimmune Hepatitis

Interventions

DRUG: Orencia® (Abatacept)

Sponsor

Stuart Knechtle, M.D.